{"publishers": ["National Academy Press"], "number_of_pages": 269, "isbn_10": ["0309052793"], "covers": [2361619], "lc_classifications": ["RC848.H44 R48 1995", "RC848.H44R48 1995", "RC848.H44 R48 1995eb"], "key": "/books/OL818331M", "publish_places": ["Washington, DC"], "contributions": ["Manning, Frederick J.", "Swartz, Morton N."], "pagination": "ix, 269 p. ;", "source_records": ["ia:reviewfialuridin00fial", "ia:reviewoffialurid0000unse", "ia:reviewoffialurid0000unse_b0i3", "bwb:9780309052795", "marc:marc_loc_2016/BooksAll.2016.part24.utf8:133235312:979", "marc:marc_columbia/Columbia-extract-20221130-009.mrc:48465224:1464", "promise:bwb_daily_pallets_2021-08-19", "marc:harvard_bibliographic_metadata/20220215_033.bib.mrc:256328328:2376"], "title": "Review of the Fialuridine (FIAU) clinical trials", "dewey_decimal_class": ["616.3/623061"], "notes": {"type": "/type/text", "value": "Includes bibliographical references (p. 165-177).\n\"Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Division of Health Sciences Policy, Institute of Medicine\"."}, "identifiers": {"goodreads": ["2903172"], "librarything": ["8151451"]}, "languages": [{"key": "/languages/eng"}], "lccn": ["95068327"], "subjects": ["Hepatitis B -- Chemotherapy -- Evaluation.", "Fialuridine -- Testing.", "Fiacitabine -- Testing.", "Clinical trials -- Safety measures."], "publish_date": "1995", "publish_country": "dcu", "by_statement": "Frederick J. Manning and Morton Swartz, editors.", "oclc_numbers": ["33042180", "32227546"], "works": [{"key": "/works/OL19604824W"}], "type": {"key": "/type/edition"}, "local_id": ["urn:bwbsku:TG-920-346"], "latest_revision": 17, "revision": 17, "created": {"type": "/type/datetime", "value": "2008-04-01T03:28:50.625462"}, "last_modified": {"type": "/type/datetime", "value": "2026-03-28T10:57:29.087466"}}